Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Shauna Levy

Surgery New Orleans, LA Medical Doctor

NPI 1740535293 CMS profile 170633

1415 Tulane Ave, New Orleans, LA 70112

Open in the dashboard

General payments

$33,125

121 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Shauna Levy of New Orleans, LA is reported in the CMS Open Payments database as having received $33,125 across 121 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,266 21
2024 General $1,713 19
2023 General $16,102 17
2022 General $2,968 10
2021 General $188 4
2020 General $1,921 17
2019 General $8,967 33

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Shauna Levy
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to Shauna Levy were reported at $1,266. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year Shauna Levy Surgery median Middle half National median
2019 $8,967 $253 $82–$1,521 $163
2020 $1,921 $131 $40–$706 $114
2021 $188 $168 $50–$904 $132
2022 $2,968 $224 $76–$1,218 $149
2023 $16,102 $253 $82–$1,255 $160
2024 $1,713 $279 $90–$1,381 $164
2025 $1,266 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Intuitive Surgical, Inc. $14,014 39 payments
  2. Ethicon Inc. $11,933 6 payments
  3. Heron Therapeutics, Inc. $2,338 3 payments
  4. Merck Sharp & Dohme Corporation $1,250 2 payments
  5. Medical Device Business Services, Inc. $711 8 payments
  6. Novo Nordisk Inc $676 16 payments
  7. Ethicon US, LLC $659 11 payments
  8. Allergan Inc. $320 12 payments
  9. Teleflex LLC $294 5 payments
  10. Medtronic, Inc. $180 2 payments
  11. Other $751 17 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $14,403 4 payments
  2. Education $11,000 4 payments
  3. Food and Beverage $4,664 98 payments
  4. Travel and Lodging $3,030 14 payments
  5. Gift $28 1 payment
Products named General payments · program years 2019–2025
  1. Da Vinci Surgical System $11,014 38 payments
  2. DAVINCI XI $3,000 1 payment
  3. Zynrelef $2,313 2 payments
  4. LINX Reflux Management System Endo-Mechanical $685 7 payments
  5. Wegovy $623 13 payments
  6. ECHELON FLEX Stapler $393 6 payments
  7. STRATTICE $204 8 payments
  8. Titan SGS $129 2 payments
  9. Echelon Flex $127 1 payment
  10. LINX Reflux Management System Endo-Mechanical $127 1 payment
  11. Other $1,617 38 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

12

Median for General Surgery: 59

Drug cost

$133

Median for General Surgery: $393

Branded share of claims

100%

Median for General Surgery: 28.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ondansetron Odt Ondansetron Brand 12 $133

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 15,891 Part D prescribers listed as General Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 11 billing codes

Paid by Medicare

$3,923

Medicare's payments for the services billed

Medicare patients

23

Average age 66

Services billed

27

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 61%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Wegovy
  • Novo Nordisk Inc $293
$293 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

121 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in Louisiana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record